Skip to main content

Earlier breast screening for Black women may reduce racial mortality gaps

Doctor looking at mammogram

Initiating biennial breast screening for Black women at age 40 years rather than the US standard of 50 years could substantially reduce Black–White breast cancer mortality disparities without increasing harms, modelling data suggest.


Data favor TNF inhibitor monotherapy for IMIDs during COVID-19 pandemic

Corona Virus covid-19 illustration with dark blue cell background

TNF inhibitor monotherapy is associated with a lower risk for COVID-19-related hospitalization or death than other common immunomodulatory treatments given to people with immune-mediated inflammatory diseases, research suggests.

Headlines from across medwireNews

20-10-2021 | Rheumatology | News | Article

EMA recommends expanding risankizumab indication to include PsA

Click through to read more about this announcement

20-10-2021 | Oncology | News | Article

Adjuvant atezolizumab approved by FDA for NSCLC patients

For more information on the approval, click here

20-10-2021 | Diabetes | News | Article

Insulin sensitivity may impact partial remission phase of early type 1 diabetes

Insulin sensitivity may be associated with the likelihood of partial remission in children and adolescents newly diagnosed with type 1 diabetes, regardless of C-peptide levels and BMI, research suggests.

19-10-2021 | Diabetes | News | Article

Tirzepatide preferable to glargine when OADs fail in SURPASS-4

Tirzepatide provides better glucose control than insulin glargine in people with type 2 diabetes taking multiple oral antidiabetes medications, report the SURPASS-4 investigators in The Lancet.

19-10-2021 | Rheumatology | News | Article

Tofacitinib receives EMA support for ankylosing spondylitis

More information about this decision here

19-10-2021 | Oncology | News | Article

EMA gives green light for first-line use of lenvatinib plus pembrolizumab in advanced RCC

Click through for the details of this positive opinion

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team

Image Credits